A medication previously approved to treat melanoma that cannot be removed by surgery just got the approval it needed for another melanoma-related use.

A new FDA approval suggests that, sometimes, two medications may be better than one.

Once melanoma skin cancer spreads to other parts of the body, patients' survival rates drop. But treatment with a combination of medications may increase survival in these patients.

One of the most promising fields in cancer research and treatment looks at ways to enable the body’s own immune system to fight off cancer. This is called immunotherapy and is giving some cancer patients more years of life.

There’s no need to suffer in silence. Side effects of melanoma medications can be managed, but only if the patient tells the doctor about all of the symptoms as soon as they appear.

When it’s the body against cancer, the body has to win at all costs. Getting the better of melanoma may require the immune system taking one for the team.